Previously, it has been shown that Myozap transgenic mice develop a protein-aggregate-associated cardiomyopathy with dysregulation of UPR signalling, induction of autophagy and apoptosis (Frank et al., 2014). Here, MYZAP is linked to cardiomyopathy.